ducovest

HUM:NYE-Humana Inc.

EQUITY | Health Care Plans | New York Stock Exchange

Last Closing

USD 251.83

Change

0.00 (0.00)%

Market Cap

USD 30.56B

Volume

0.97M

Analyst Target

USD 321.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Humana Inc is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group and Healthcare Services.

Company Website : http://www.humana.com

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-06-16 )

Largest Industry Peers for Health Care Plans

ETFs Containing HUM

LONG:CA CI Global Longevity Econo.. 4.30 % 0.00 %

N/A

 CAD 0.07B
IHF iShares U.S. Healthcare P.. 4.20 % 0.43 %

+0.15 (+-0.37%)

 USD 0.82B
PINK Simplify Exchange Traded .. 3.50 % 0.00 %

-0.06 (-0.37%)

 USD 0.13B
DXQ:CA Dynamic Active Enhanced Y.. 2.28 % 0.00 %

-0.09 (-0.37%)

 CAD 0.38B
TUSB:CA TD Select U.S. Short Term.. 2.16 % 0.28 %

+0.08 (+-0.37%)

 CAD 7.90M
TUSB-U:CA TD Select U.S. Short Term.. 2.16 % 0.00 %

N/A

 CAD 7.90M
FUM:CA 0.00 % 0.80 %

N/A

 N/A
VETS 0.00 % 0.60 %

N/A

 N/A
HIG-U:CA 0.00 % 0.00 %

N/A

 N/A
GBLO 0.00 % 0.00 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Care Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.10% 38% F 9% A-
Dividend Return 0.19% 40% F 5% F
Total Return -11.90% 38% F 8% B-
Trailing 12 Months  
Capital Gain -17.96% 25% F 22% F
Dividend Return 0.67% 40% F 8% B-
Total Return -17.29% 25% F 20% F
Trailing 5 Years  
Capital Gain 104.66% 38% F 92% A
Dividend Return 5.93% 40% F 19% F
Total Return 110.59% 38% F 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 20.59% 38% F 93% A
Dividend Return 21.33% 38% F 92% A
Total Return 0.74% 40% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 18.34% 75% C 39% F
Risk Adjusted Return 116.32% 75% C 92% A
Market Capitalization 30.56B 50% F 95% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Care Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 27.50 25% 32%
Price/Book Ratio 3.22 63% 23%
Price / Cash Flow Ratio 5.70 25% 19%
Price/Free Cash Flow Ratio 22.38 63% 25%
Management Effectiveness  
Return on Equity 16.40% 75% 77%
Return on Invested Capital N/A N/A N/A
Return on Assets 5.58% 75% 72%
Debt to Equity Ratio 51.50% 88% 61%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.